BIOMAT Database Logo BIOMAT Database Logo

SEPARATION OF HUMAN INSULIN, GLUCAGON AND OTHER PANCREATIC PROTEINS. 1964

V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010184 Pancreatic Extracts Extracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities. PANCREATIN is a specific extract containing digestive enzymes and used to treat pancreatic insufficiency. Pancreatic Extract,Pancreatic Tissue Extract,Pancreatic Tissue Extracts,Extract, Pancreatic,Extract, Pancreatic Tissue,Extracts, Pancreatic,Extracts, Pancreatic Tissue,Tissue Extract, Pancreatic,Tissue Extracts, Pancreatic
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D004586 Electrophoresis An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current. Electrophoreses
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor

Related Publications

V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
Insulin and glucagon in human pancreatic exocrine fluid.
January 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.
January 1983, International journal of obesity,
V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
[Quantitative electophoretic separation of insulin and glucagon].
April 1968, Die Naturwissenschaften,
V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
Stimulation of liver regeneration by pancreatic hepatotrophic factors other than insulin and glucagon.
January 1978, Surgical forum,
V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
Plasma pancreatic glucagon and insulin: glucagon ratio at birth.
March 1973, Archives of disease in childhood,
V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
Regulation of pancreatic insulin and glucagon secretion.
January 1976, Annual review of physiology,
V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
Pancreatic glucagon and insulin response during surgery.
August 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
Glucagon and insulin in pancreatic exocrine secretions.
June 1979, Lancet (London, England),
V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
ANABOLIC RESPONSES OF DIAPHRAGM MUSCLE TO INSULIN AND TO OTHER PANCREATIC PROTEINS.
July 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V LOCHNERJDE, and A C ESTERHUIZEN, and R H UNGER
Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illnesses.
December 1971, Diabetes,
Copied contents to your clipboard!